FR2368473A1 - O-nor-aromatique-13,14-dehydro-prostaglandines, leur procede de preparation et leur utilisation comme contraceptifs - Google Patents

O-nor-aromatique-13,14-dehydro-prostaglandines, leur procede de preparation et leur utilisation comme contraceptifs

Info

Publication number
FR2368473A1
FR2368473A1 FR7716727A FR7716727A FR2368473A1 FR 2368473 A1 FR2368473 A1 FR 2368473A1 FR 7716727 A FR7716727 A FR 7716727A FR 7716727 A FR7716727 A FR 7716727A FR 2368473 A1 FR2368473 A1 FR 2368473A1
Authority
FR
France
Prior art keywords
aromatique
dehydro
contraceptives
prostaglandins
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7716727A
Other languages
English (en)
Other versions
FR2368473B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Carlo Erba SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT2382676A external-priority patent/IT1060884B/it
Priority claimed from IT3045876A external-priority patent/IT1065450B/it
Application filed by Carlo Erba SpA filed Critical Carlo Erba SpA
Publication of FR2368473A1 publication Critical patent/FR2368473A1/fr
Application granted granted Critical
Publication of FR2368473B1 publication Critical patent/FR2368473B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)

Abstract

Les composés de l'invention, qui sont optiquement actifs ou racémiques, ont pour formule :
FR7716727A 1976-06-01 1977-06-01 O-nor-aromatique-13,14-dehydro-prostaglandines, leur procede de preparation et leur utilisation comme contraceptifs Granted FR2368473A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2382676A IT1060884B (it) 1976-06-01 1976-06-01 Aromatiche prostaglandine
IT3045876A IT1065450B (it) 1976-12-16 1976-12-16 Oxaprostaglandine

Publications (2)

Publication Number Publication Date
FR2368473A1 true FR2368473A1 (fr) 1978-05-19
FR2368473B1 FR2368473B1 (fr) 1981-09-11

Family

ID=26328426

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7716727A Granted FR2368473A1 (fr) 1976-06-01 1977-06-01 O-nor-aromatique-13,14-dehydro-prostaglandines, leur procede de preparation et leur utilisation comme contraceptifs

Country Status (18)

Country Link
US (1) US4195183A (fr)
JP (1) JPS52148044A (fr)
AT (2) AT356302B (fr)
AU (1) AU509127B2 (fr)
BE (1) BE855236A (fr)
CA (1) CA1115700A (fr)
CH (1) CH634831A5 (fr)
CS (1) CS192484B2 (fr)
DE (1) DE2721534A1 (fr)
DK (1) DK233377A (fr)
FR (1) FR2368473A1 (fr)
GB (1) GB1583263A (fr)
HU (1) HU181424B (fr)
IL (1) IL51877A (fr)
NL (1) NL7705701A (fr)
NZ (1) NZ184187A (fr)
SE (1) SE436026B (fr)
SU (1) SU932985A3 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2517302A1 (fr) * 1981-11-27 1983-06-03 Erba Farmitalia Esters et amides de 13 14-bisdehydroprostaglandines

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5972991A (en) 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
AU2003213610B2 (en) * 2002-03-01 2008-04-03 Allergan, Inc. Preparation of prostamides
US7851504B2 (en) 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US9241918B2 (en) 2005-03-16 2016-01-26 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
WO2011046569A1 (fr) * 2009-10-16 2011-04-21 Cayman Chemical Company Procédé de préparation de prostaglandines de la série f
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure
JP2020034682A (ja) 2018-08-29 2020-03-05 キオクシア株式会社 露光方法、露光制御装置および半導体装置の製造方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2313029A1 (fr) * 1975-03-21 1976-12-31 Erba Carlo Spa Fluoroprostaglandines, procede permettant leur preparation, et leur utilisation therapeutique
FR2323379A1 (fr) * 1975-09-10 1977-04-08 Univ Chicago Nouveaux composes a activite pharmacologique

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2313029A1 (fr) * 1975-03-21 1976-12-31 Erba Carlo Spa Fluoroprostaglandines, procede permettant leur preparation, et leur utilisation therapeutique
FR2323379A1 (fr) * 1975-09-10 1977-04-08 Univ Chicago Nouveaux composes a activite pharmacologique

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2517302A1 (fr) * 1981-11-27 1983-06-03 Erba Farmitalia Esters et amides de 13 14-bisdehydroprostaglandines

Also Published As

Publication number Publication date
IL51877A (en) 1981-09-13
HU181424B (en) 1983-07-28
SE436026B (sv) 1984-11-05
IL51877A0 (en) 1977-06-30
CH634831A5 (en) 1983-02-28
CS192484B2 (en) 1979-08-31
AT367747B (de) 1982-07-26
GB1583263A (en) 1981-01-21
ATA333477A (de) 1979-09-15
BE855236A (fr) 1977-11-30
DK233377A (da) 1977-12-02
AU509127B2 (en) 1980-04-24
DE2721534A1 (de) 1977-12-15
NL7705701A (nl) 1977-12-05
ATA383179A (de) 1981-12-15
CA1115700A (fr) 1982-01-05
FR2368473B1 (fr) 1981-09-11
SE7706310L (sv) 1977-12-02
JPS6140662B2 (fr) 1986-09-10
AU2465677A (en) 1978-11-02
NZ184187A (en) 1978-07-28
JPS52148044A (en) 1977-12-08
US4195183A (en) 1980-03-25
AT356302B (de) 1980-04-25
SU932985A3 (ru) 1982-05-30

Similar Documents

Publication Publication Date Title
FR2416891A1 (fr) 6-n-propyl-8-methoxymethyl ou methylmercaptomethylergolines et composes apparentes, et leur utilisation therapeutique
FR2381763A1 (fr) Dibenzo(b-e) (diazepines-1,4) et leur utilisation comme antischizophreniques
FR2430934A1 (fr) Nouveaux prostanoides et procede pour leur preparation
FR2444681A1 (fr) Nouvelles 1,4-dihydropyridines, leur preparation et leur application comme medicaments
FR2446283A1 (fr) Phenoxyphenylpiperidines, leur preparation et leurs applications therapeutiques
FR2381762A1 (fr) Dibenzodiazepines utilisables comme antischizophreniques
FR2368473A1 (fr) O-nor-aromatique-13,14-dehydro-prostaglandines, leur procede de preparation et leur utilisation comme contraceptifs
FR2360635A1 (fr) Nouveaux composes hexakis-azoiques, leur preparation et leur utilisation comme colorants
FR2362822A1 (fr) Diamines cycloaliphatiques et leur utilisation comme catalyseurs pour les reactions de polyaddition de polyisocyanate
FR2362122A1 (fr) Nouvelles 3-(2-aryl-2-propyl)urees, et leur utilisation comme herbicides
FR2366276A1 (fr) Aza-13 prostaglandines
FR2397419A1 (fr) Dihydrotriazinylthiooxacephalosporines et leur utilisation comme agents antimicrobiens
FR2378752A1 (fr) Nouveaux diurethanes utiles comme herbicides
FR2369276A1 (fr) Nouve
FR2434805A1 (fr) 1-benzoyl-3-pyridinylurees, leur preparation et leur utilisation comme insecticides
FR2434806A1 (fr) 1-(2,6-dihalobenzoyl)-3-(2-pyridinyl-5-substitue) urees, leur preparation et leur utilisation comme insecticides
FR2382431A1 (fr) Nouvelles 2-hydroxy-propylamines, leur preparation et leur utilisation comme agents tensio-actifs
FR2392020A1 (fr) Nouvelles amidines, leur procede de preparation et leur utilisation comme anti-inflammatoires
FR2357610A1 (fr) Colorants nitro-amino-azoiques dispersables, leur obtention et leur application
FR2442236A1 (fr)
FR2445838A1 (fr) Nouveaux 1a,3b-dihydroxy-5-steroides
FR2446835A1 (fr) Octahydro-2h-pyrrolo(3,4-g)quinoleines utiles comme intermediaires
FR2357613A2 (fr) Colorants cationiques, leur obtention et leur application
FR2376155A1 (fr) Thiophosphorylguanidines anti-parasitaires et leur preparation
FR2371426A1 (fr) Nouvelles 15,16-dihydroxyprostaglandines, et leur utilisation therapeutique comme inhibiteurs de la secretion gastrique

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse